https://www.hcplive.com/view/systemic-ocular-risk-factors-predict-treatment-aflibercept-dme
0
0
9/14/23 at 10:05pm
Organization
Hcplive.com
Author
Connor Iapoce
34 words
0
Comments
Factors including a longer diabetes duration and lower eGFR were associated with suboptimal treatment response to aflibercept in patients with DME.
You are the first to view
Create an account
or login to join the discussion